Characteristics of Lipid Metabolism Disorders in Patients with Metabolic Syndrome and the Clinical Significance of Atherogenic Dyslipidemia
Scientific and Innovative Therapy · 2025
DOI: 10.64582/ivit.uz.261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2025. Verfasst von Dilobar Tursunova und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Dyslipidemia is a condition characterized by abnormal levels of lipids (fats) in the blood, particularly cholesterol and triglycerides. It may manifest as an increase in “bad” cholesterol (LDL-C) or triglyceride levels and a decrease in “good” cholesterol (HDL-C) levels. Long-term dyslipidemia can lead to the development of atherosclerosis and cardiovascular diseases.
Zitieren
APA
Tursunova, D., & Badritdinova, M. (2025). Characteristics of Lipid Metabolism Disorders in Patients with Metabolic Syndrome and the Clinical Significance of Atherogenic Dyslipidemia. Scientific and Innovative Therapy. https://doi.org/10.64582/ivit.uz.261
Vancouver
Tursunova D, Badritdinova M. Characteristics of Lipid Metabolism Disorders in Patients with Metabolic Syndrome and the Clinical Significance of Atherogenic Dyslipidemia. Scientific and Innovative Therapy. 2025. doi:10.64582/ivit.uz.261
BibTeX
@article{Tursunova2025,
author = {Tursunova, Dilobar and Badritdinova, Matluba},
title = {Characteristics of Lipid Metabolism Disorders in Patients with Metabolic Syndrome and the Clinical Significance of Atherogenic Dyslipidemia},
journal = {Scientific and Innovative Therapy},
year = {2025},
doi = {10.64582/ivit.uz.261}
}
EUVIMED